12.00
전일 마감가:
$11.92
열려 있는:
$11.91
하루 거래량:
209.34K
Relative Volume:
0.93
시가총액:
$141.32M
수익:
$1.07B
순이익/손실:
$99.41M
주가수익비율:
1.3245
EPS:
9.06
순현금흐름:
$141.17M
1주 성능:
-7.12%
1개월 성능:
-16.32%
6개월 성능:
-32.43%
1년 성능:
-63.01%
Medifast Inc Stock (MED) Company Profile
명칭
Medifast Inc
전화
(732) 764-0619
주소
11445 CRONHILL DRIVE, OWINGS MILLS, MD
MED을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MED
Medifast Inc
|
12.00 | 141.32M | 1.07B | 99.41M | 141.17M | 9.06 |
![]()
ROL
Rollins Inc
|
54.73 | 26.51B | 3.39B | 466.38M | 580.08M | 0.96 |
![]()
SCI
Service Corp International
|
76.59 | 11.37B | 4.15B | 505.69M | 587.50M | 3.44 |
![]()
HRB
H R Block Inc
|
59.63 | 8.13B | 3.62B | 586.22M | 657.77M | 4.10 |
![]()
BFAM
Bright Horizons Family Solutions Inc
|
113.39 | 6.78B | 2.63B | 116.59M | 215.93M | 1.99 |
![]()
FTDR
Frontdoor Inc
|
39.64 | 2.98B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-05 | 업그레이드 | DA Davidson | Underperform → Neutral |
2024-06-05 | 다운그레이드 | DA Davidson | Neutral → Underperform |
2023-10-13 | 개시 | Stephens | Equal-Weight |
2022-11-04 | 다운그레이드 | DA Davidson | Buy → Neutral |
2022-08-04 | 다운그레이드 | Jefferies | Buy → Hold |
2021-01-25 | 업그레이드 | Jefferies | Hold → Buy |
2020-11-05 | 업그레이드 | DA Davidson | Neutral → Buy |
2020-06-25 | 개시 | B. Riley FBR | Buy |
2020-02-27 | 다운그레이드 | Jefferies | Buy → Hold |
2019-11-08 | 다운그레이드 | Dougherty & Company | Buy → Neutral |
2019-07-25 | 개시 | Jefferies | Buy |
2018-11-08 | 업그레이드 | Sidoti | Neutral → Buy |
2018-03-07 | 업그레이드 | Sidoti | Neutral → Buy |
2017-09-15 | 재확인 | DA Davidson | Buy |
2016-08-04 | 재확인 | Wunderlich | Hold |
2016-01-11 | 업그레이드 | Sidoti | Neutral → Buy |
2015-11-30 | 다운그레이드 | Sidoti | Buy → Neutral |
2015-10-05 | 업그레이드 | Sidoti | Neutral → Buy |
2014-11-07 | 다운그레이드 | Imperial Capital | Outperform → In-line |
2014-08-08 | 재확인 | Imperial Capital | Outperform |
2014-04-23 | 재확인 | Imperial Capital | Outperform |
2013-09-06 | 개시 | Imperial Capital | Outperform |
2012-11-06 | 재확인 | Northland Securities | Outperform |
2012-07-27 | 업그레이드 | Northland Securities | Market Perform → Outperform |
2012-07-09 | 다운그레이드 | Standpoint Research | Buy → Hold |
2012-01-30 | 개시 | Standpoint Research | Buy |
모두보기
Medifast Inc 주식(MED)의 최신 뉴스
Medifast to Report Q1 Earnings: What Investors Should Expect - TradingView
Medifast Trades Near 52-Week Low: What's the Best Move Now? - MSN
Medifast stock hits 52-week low at $12.27 amid sharp decline By Investing.com - Investing.com South Africa
Medifast stock hits 52-week low at $12.27 amid sharp decline - Investing.com Australia
Medifast Q1 2025 Earnings Coming April 28: CEO to Detail OPTAVIA Performance - Stock Titan
Arrowstreet Capital Limited Partnership Sells 180,332 Shares of Medifast, Inc. (NYSE:MED) - Defense World
Medifast stock hits 52-week low at $14.88 amid sharp decline - MSN
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript - MSN
Personal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED) - The Globe and Mail
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Medifast, Inc. (MED) - ACCESS Newswire
Prudential Financial Inc. Lowers Holdings in Medifast, Inc. (NYSE:MED) - Defense World
3 Reasons MED is Risky and 1 Stock to Buy Instead - Yahoo Finance
Critical Comparison: Medifast (NYSE:MED) vs. Top Wealth Group (NASDAQ:TWG) - Defense World
American Century Companies Inc. Boosts Stock Position in Medifast, Inc. (NYSE:MED) - Defense World
Medifast stock hits 52-week low at $12.8 amid sharp decline - Investing.com Canada
Medifast stock hits 52-week low at $12.8 amid sharp decline By Investing.com - Investing.com South Africa
Medifast, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Medifast (MED) - ACCESS Newswire
With 78% ownership, Medifast, Inc. (NYSE:MED) boasts of strong institutional backing - Yahoo
Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect (NYSE:MED) - Seeking Alpha
Medifast stock plunges to 52-week low at $13.55 amid sharp decline - Investing.com Australia
Medifast stock plunges to 52-week low at $13.55 amid sharp decline By Investing.com - Investing.com South Africa
How Is The Market Feeling About Medifast? - Benzinga
Amundi Invests $374,000 in Medifast, Inc. (NYSE:MED) - Defense World
Zacks Research Forecasts Medifast’s Q1 Earnings (NYSE:MED) - Defense World
What is Zacks Research’s Estimate for Medifast Q2 Earnings? - Defense World
LifeMD, Inc. SEC 10-K Report - TradingView
Medifast, Inc. to Host Earnings Call - ACCESS Newswire
Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Medifast (NYSE:MED) Issues Q1 2025 Earnings Guidance - MarketBeat
Institutional owners may take dramatic actions as Medifast, Inc.'s (NYSE:MED) recent 11% drop adds to one-year losses - Simply Wall St
Medifast Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition - MSN
Medifast stock target cut to $16.50 by DA Davidson - Investing.com UK
Medifast (MED) PT Lowered to $16.50 at DA Davidson - StreetInsider.com
Medifast Reports Financial Results for Q4 and Full Year 2024 - Direct Selling News
Medifast stock hits 52-week low at $14.76 amid sharp decline - Investing.com
Medifast stock hits 52-week low at $14.76 amid sharp decline By Investing.com - Investing.com South Africa
Medifast Beats Revenue Expectations Amidst Sharp Sales DeclineNews and Statistics - IndexBox, Inc.
Medifast: Q4 Earnings Snapshot - mySA
Medifast Inc (MED) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Earnings call transcript: Medifast Q4 2024 beats EPS, misses revenue By Investing.com - Investing.com Canada
Medifast Reports 2024 Financial Results Amid Market Challenges - TipRanks
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions - MSN
Medifast Inc (MED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):